VEGFA and neovascular glaucoma: Patients in group 3 (those with neovascular glaucoma that was refractory to treatment) had higher levels of IL-6, TGFβ-1, and VEGF compared with patients in PDR group 1 and PDR group 2 (the nonneovascular glaucoma groups).